Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 07.09.2026 1 ACS Nano 1 Biochem Genet 1 Cardiovasc J Afr 1 Case Rep Anesthesiol 1 Cell Prolif 1 Chest 2 Circulation 2 Clin Rheumatol 1 Curr Opin Rheumatol 1 ERJ Open Res 1 Eur Heart J 1 Eur Heart J Cardiovasc Imaging 1 Eur Heart J Open 1 Eur J Pharmacol 1 Folia Med (Plovdiv) 2 Front Cardiovasc Med 1 Front Med (Lausanne) 1 Front Pediatr 1 Front Public Health 1 Geroscience 1 Heart Lung 1 Int J Obstet Anesth 1 Intern Med 1 J Heart Lung Transplant 1 J Pharmacol Exp Ther 1 J Proteomics 1 J Vis Exp 1 Korean J Radiol 1 N Engl J Med 1 NMR Biomed 3 Pulm Circ 1 Rev Cardiovasc Med 1 Sci Transl Med 1 Semin Cardiothorac Vasc Anesth 2 Ther Adv Respir Dis 1 Vascul Pharmacol 1 Zhongguo Zhong Yao Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Nano

1. CANTOR HJ, Zhu D, Li Z, Hu S, et al
   Therapeutic Reversal of PH-HFpEF via Lung Spheroid Cell Exosomes.
   ACS Nano. 2026;20:23871-23883.
   PubMed         Abstract available
   
   

   
   Biochem Genet

2. YE P, Zhu L, Chu P, Wang D, et al
   Secretory Carrier Membrane Protein 3 Knockdown Attenuates Hypoxic Pulmonary Hypertension Potentially Involving WW Domain-Containing E3 Ubiquitin Protein Ligase 1.
   Biochem Genet. 2026 Sep 2. doi: 10.1007/s10528-026-11446.
   PubMed         Abstract available
   
   

   
   Cardiovasc J Afr

3. HENEMA MMF, Brown SC, Smit FE, Botes L, et al
   An analysis of imaging modalities to assess the right and left heart in pulmonary hypertension with left-to-right shunts.
   Cardiovasc J Afr. 2026;37:345-353.
   PubMed         Abstract available
   
   

   
   Case Rep Anesthesiol

4. EL KAISSI J, Laoutid J
   Continuous Spinal Anesthesia in a High-Risk Patient With Pulmonary Hypertension Undergoing Hip Fracture Repair: A Case Report.
   Case Rep Anesthesiol. 2026;2026:5262622.
   PubMed         Abstract available
   
   

   
   Cell Prolif

5. JIANG S, Tian L, Qu J, Hong Y, et al
   Human iPSC-Derived Vascularised Lung Organoids for Modelling COPD and Pulmonary Hypertension.
   Cell Prolif. 2026 Sep 1:e70273. doi: 10.1111/cpr.70273.
   PubMed         Abstract available
   
   

   
   Chest

6. D'ALTO M, Cangiano N, Orlando A, Argiento P, et al
   Multicenter invasive validation of the Venous Excess Ultrasound Score (VExUS) in patients referred for pulmonary hypertension.
   Chest. 2026 Aug 29:S0012-3692(26)06526-8. doi: 10.1016/j.chest.2026.
   PubMed         Abstract available
   
   

   
   Circulation

7. LYNCH PT, Makkapati S, George JC, Vaidya A, et al
   Left Circumflex Coronary-Pulmonary Arterial Collaterals in Chronic Thromboembolic Pulmonary Hypertension.
   Circulation. 2026;154:872.
   PubMed        
   
   
8. ZHANG J, Li Y, He M, Tan J, et al
   PUS7-Mediated Pseudouridylation of TGFBI Drives Vascular Remodeling in Pulmonary Hypertension.
   Circulation. 2026 Sep 1. doi: 10.1161/CIRCULATIONAHA.126.080714.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

9. ZHUANG S, Zheng L, Wang X, Pu J, et al
   The clinical characteristics and risk factors of pulmonary arterial hypertension in primary Sjogren disease: a single-center retrospective study.
   Clin Rheumatol. 2026;45:5615-5624.
   PubMed         Abstract available
   
   
10. PARK HW, Park Y, Lee JJ, Ju JH, et al
    Clinical characteristics and factors associated with progressive pulmonary fibrosis in patients with systemic sclerosis-associated interstitial lung disease.
    Clin Rheumatol. 2026;45:5585-5595.
    PubMed         Abstract available
    
    

    
    Curr Opin Rheumatol

11. YAKU A, Mylvaganam RJ, Shah SJ
    Redefining systemic sclerosis-associated pulmonary hypertension as an immune-mediated vasculopathy across the cardiopulmonary circulation.
    Curr Opin Rheumatol. 2026 Sep 3. doi: 10.1097/BOR.0000000000001202.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

12. CHANGELA S, Hadidchi R, Madan J, Henry SS, et al
    Elevated risk of first-time pulmonary hypertension among COVID-19 survivors: a 4.5-year longitudinal study.
    ERJ Open Res. 2026;12:01768-2025.
    PubMed         Abstract available
    
    

    
    Eur Heart J

13. AL-QAZAZI R, Emon IM, Potus F, Martin AY, et al
    Germline and somatic variants in DNMT3A and other clonal haematopoiesis of indeterminate potential genes contribute to pulmonary arterial hypertension.
    Eur Heart J. 2025 Aug 29:ehaf611. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur Heart J Cardiovasc Imaging

14. MOURA-FERREIRA S, Milani M, Dhont S, L'Hoyes W, et al
    Risk stratification in aortic stenosis: exercise haemodynamics to refine risk in early cardiac damage stages.
    Eur Heart J Cardiovasc Imaging. 2026;27:1686-1698.
    PubMed         Abstract available
    
    

    
    Eur Heart J Open

15. WICK C, Lichtblau M, Titz A, Muller J, et al
    Effect of low-flow oxygen therapy on 6 minute walk test in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomized non-inferiority crossover trial.
    Eur Heart J Open. 2026;6:oeag125.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

16. GUEVARA YAS, Gonzaga-Costa K, Calixto GL, Diaz LC, et al
    Therapeutic effects of trans-3-methoxy-beta-nitrostyrene in rat model of monocrotaline-induced pulmonary hypertension.
    Eur J Pharmacol. 2026 Sep 4:179310. doi: 10.1016/j.ejphar.2026.179310.
    PubMed         Abstract available
    
    

    
    Folia Med (Plovdiv)

17. MILANOVA-ILIEVA D, Ketev K, Karavelikova I, Chochkova-Bukova L, et al
    Long-term management of a child with aortopulmonary septal defect and Eisenmenger syndrome: a 6-year follow-up case study.
    Folia Med (Plovdiv). 2026;68.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

18. LUO L, Wang X, Huang K, Yang Y, et al
    Anomalous origin of the left coronary artery from the pulmonary artery with coronary artery fistula in an adult presenting with cardiomegaly, abnormal electrocardiogram, myocardial perfusion defect and pulmonary hypertension: a case report.
    Front Cardiovasc Med. 2026;13:1844272.
    PubMed         Abstract available
    
    
19. SAWCZAK F, Kukfisz A, Dudek M, Straburzynska-Migaj E, et al
    Relationship between right heart catheterization and exercise testing in heart failure patients with and without pulmonary hypertension - cross-sectional study.
    Front Cardiovasc Med. 2026;13:1812393.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

20. NISHIYAMA M, Okada T, Teranaka W, Naruko T, et al
    Chronic thromboembolic pulmonary hypertension: towards an etiology-oriented conceptual framework.
    Front Med (Lausanne). 2026;13:1910552.
    PubMed         Abstract available
    
    

    
    Front Pediatr

21. LI Y, Huang J, Zhang X, Liu Y, et al
    Internet-Based home care education for children with pulmonary hypertension: a public health perspective.
    Front Pediatr. 2026;14:1759723.
    PubMed         Abstract available
    
    

    
    Front Public Health

22. LI W, Ke X, Ma J, Jin R, et al
    Patients' perspectives on pulmonary rehabilitation for pulmonary hypertension in high-altitude areas: a mixed-methods study.
    Front Public Health. 2026;14:1869309.
    PubMed         Abstract available
    
    

    
    Geroscience

23. MADONNA R, Del Boccio P, Borghini A, Alberti M, et al
    Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension.
    Geroscience. 2026 Aug 31. doi: 10.1007/s11357-026-02497.
    PubMed         Abstract available
    
    

    
    Heart Lung

24. BARBERO C, Loforte A, Scala V, Trompeo AC, et al
    Emergent simultaneous cesarean section and maternal cardiac surgery.
    Heart Lung. 2026;79:102820.
    PubMed         Abstract available
    
    

    
    Int J Obstet Anesth

25. KRUTHOF J, De Haes J
    Changing paradigm in pulmonary hypertension during pregnancy: from universal contraindication to individualized management.
    Int J Obstet Anesth. 2026;68:105272.
    PubMed        
    
    

    
    Intern Med

26. KADOTA M, Yagi S, Akagi S, Kasahara S, et al
    Treat-and-repair Strategy for Atrial Septal Defect with Eisenmenger Syndrome due to Pulmonary Arterial Hypertension.
    Intern Med. 2026;65:2346-2351.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

27. ERSBOLL MK, Kjaergaard J, Waidtlow K, Kober L, et al
    Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial.
    J Heart Lung Transplant. 2026 Aug 31:S1053-2498(26)01987.
    PubMed         Abstract available
    
    

    
    J Pharmacol Exp Ther

28. LU GF, Guo Y, Geng F
    Circular RNAs regulate the progression of pulmonary hypertension through distinct roles and mechanisms.
    J Pharmacol Exp Ther. 2026;393:104987.
    PubMed         Abstract available
    
    

    
    J Proteomics

29. TEIXEIRA M, Couto DS, Oliveira MI, Aires I, et al
    Transpulmonary proteomic gradient analysis in women with pulmonary arterial hypertension associated with systemic sclerosis.
    J Proteomics. 2026;331:105703.
    PubMed         Abstract available
    
    

    
    J Vis Exp

30. LI X, Wu L, Liu X, Li P, et al
    Warfarin Dose Adjustment During Rifampicin Therapy: A Case Report with Practical Monitoring Implications.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    Korean J Radiol

31. KIM NY, Im DJ, Hong YJ, Lee JW, et al
    Sequential Changes in Right Ventricular Straein During the Development of Pulmonary Hypertension Assessed With Magnetic Resonance Feature Tracking: An Animal Study.
    Korean J Radiol. 2026 Sep 1. doi: 10.3348/kjr.2026.0774.
    PubMed         Abstract available
    
    

    
    N Engl J Med

32. ZHANG H, Wang Q, Liang M, Chen X, et al
    Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
    N Engl J Med. 2026 Aug 30. doi: 10.1056/NEJMoa2609056.
    PubMed         Abstract available
    
    

    
    NMR Biomed

33. COSTELLE A, Leewiwatwong S, Mugler JP 3rd, Mummy D, et al
    Standardized Spectral Mapping With (129)Xe Chemical Shift Imaging: Investigating Red Blood Cell Shift Heterogeneity in Pulmonary Hypertension.
    NMR Biomed. 2026;39:e70388.
    PubMed         Abstract available
    
    

    
    Pulm Circ

34. SUN Y, Ding R, Su X, Qin L, et al
    Pulmonary Hypertension Molecular Switch: HIF Signaling Pathway.
    Pulm Circ. 2026;16:e70385.
    PubMed         Abstract available
    
    
35. WU M, Su H, Sun X, Gong S, et al
    Diffusing Capacity of the Lung for Carbon Monoxide and the Risk of All-Cause Mortality in Patients With Pulmonary Hypertension Caused by Fibrosing Mediastinitis: A Multicenter Cohort Study.
    Pulm Circ. 2026;16:e70401.
    PubMed         Abstract available
    
    
36. AVERJANOVAITE V, Gumbiene L, Zakarkaite D, Laukyte-Sleniene M, et al
    Pulmonary Function and Exercise-Based Assessments for the Detection of Pulmonary Hypertension in Fibrotic Interstitial Lung Disease.
    Pulm Circ. 2026;16:e70402.
    PubMed         Abstract available
    
    

    
    Rev Cardiovasc Med

37. LI Z, Xu X, Li J, Fang Y, et al
    Artificial Intelligence in Pulmonary Hypertension: Current State and Future Prospects.
    Rev Cardiovasc Med. 2026;27:48114.
    PubMed         Abstract available
    
    

    
    Sci Transl Med

38. BIKOU O, Halouani A, Sun Y, Bisserier M, et al
    MicroRNA-224 orchestrates BMP and TGFbeta signaling and is a therapeutic target in preclinical pulmonary arterial hypertension.
    Sci Transl Med. 2026;18:eaef6676.
    PubMed         Abstract available
    
    

    
    Semin Cardiothorac Vasc Anesth

39. GOWDA N, Lal Negi S, Puri GD, Kumar R, et al
    Net Atrioventricular Compliance: A Determinant of Pulmonary Artery Pressure in Patients Undergoing Mitral Valve Replacement for Severe Mitral Stenosis.
    Semin Cardiothorac Vasc Anesth. 2026;30:183-190.
    PubMed         Abstract available
    
    

    
    Ther Adv Respir Dis

40. ZOU Y, Ahmad A, Zhang S, Wang Y, et al
    Repurposing SGLT2 inhibitors in pulmonary arterial hypertension: A multi-center longitudinal pilot study demonstrating favorable effects on risk profile and ventricular coupling.
    Ther Adv Respir Dis. 2026;20:17534666261479969.
    PubMed         Abstract available
    
    
41. HOU P, Ke M, Jiang Q, Lai N, et al
    Cerebral hypoperfusion in pulmonary arterial hypertension: Association with right ventricular dysfunction and risk stratification.
    Ther Adv Respir Dis. 2026;20:17534666261485141.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

42. CHEN W, Dong Y, Shi Q, Meng H, et al
    Multi-omics and experimental validation reveal the proliferative mechanism of ACSL4 in pulmonary hypertension and identify potential FDA-approved drugs via in silico screening.
    Vascul Pharmacol. 2026;164:107694.
    PubMed         Abstract available
    
    

    
    Zhongguo Zhong Yao Za Zhi

43. HAN DS, Wei MM, Liu RX, Ma YG, et al
    [Effects of Gualou Xiebai Banxia Decoction on pulmonary vascular remodeling in rats with hypoxic pulmonary hypertension].
    Zhongguo Zhong Yao Za Zhi. 2026;51:4723-4733.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum